Medium/Low transparencyReviewed June 1, 2026Source-verified pricing
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
MEDVi is a Telehealth → compounding pharmacy GLP-1 provider. Transparency rating: Medium/Low. Compounded semaglutide: Verify pre-signup. Compounded tirzepatide: $199/mo advertised, $399-$499/mo at refill per third-party reports. Compounded GLP-1 telehealth.
MEDVi at a Glance
Domain
medvi.com
Founded
—
Care model
Telehealth → compounding pharmacy
Transparency rating
Medium/Low
Compounded semaglutide
Verify pre-signup
Compounded tirzepatide
$199/mo advertised, $399-$499/mo at refill per third-party reports
Dose-tier structure
Often dose-tiered at refill
Pharmacy disclosure
Verify pre-signup
State availability
Verify state availability
External link · GLP-1 Price Guide does not have an affiliate or sponsorship relationship with Medvi. Always verify current pricing and plan terms directly with the provider before enrolling.
Editor's transparent alternative
Strengths
Widely cited and accessible
Telehealth prescribing included
Trade-offs
Significant gap between $199 advertised and $399-$499 refill (per third-party reports)
Verify maintenance-dose price pre-signup
Pharmacy disclosure: verify
Pricing Transparency Analysis
MEDVi's pricing transparency reflects our v1.0 methodology evaluation across four dimensions:
Dimension
MEDVi's position
Advertised price
Verify pre-signup
True monthly cost at maintenance
Higher than advertised (varies by structure)
Dose escalation behavior
Often dose-tiered at refill
Hidden fees
Verify membership, lab, and visit fees pre-signup
Who Should Consider MEDVi
Compounded GLP-1 telehealth. The provider works best for patients who value: widely cited and accessible, telehealth prescribing included.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
What should I verify before enrolling with MEDVi?
Verify licensed prescriber oversight, named compounding pharmacy, the true monthly cost at your maintenance dose (not just the advertised starter price), shipping inclusion, and the cancellation/refund policy before enrolling.
Is MEDVi's advertised price the true monthly cost?
Advertised starter prices are not always the maintenance price. Confirm MEDVi's price at your maintenance dose, including any membership fee, shipping, and billing-term requirements, before comparing it to other providers.
How does MEDVi compare to a flat-rate provider?
Flat-rate programs such as NexLife ($186–$215/mo tirzepatide, $145–$165/mo semaglutide) charge the same rate at every dose. Compare MEDVi's true maintenance cost against that flat rate rather than the starter price.
Is MEDVi's compounded GLP-1 FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How is MEDVi's pricing verified here?
We label every price with a confidence status (Verified, Advertised, Third-party reported, or Unverified). Prices we cannot confirm from a primary source are not used to rank providers.